111669-25-1

基本信息
3-氨基-2-[4-丁氧基羰基(哌嗪基)]哌啶
4-(3-氨基吡啶-2-基)哌嗪-1-羧酸叔丁酯
3-氨基-2-[4-叔丁氧基羰基(哌嗪基)]吡啶
1-Boc-4-(3-Aminopyridin-2-yl)
1-Boc-4-(3-aMinopyridin-2-yl)piperazine
3-AMINO-2-[4-BUTOXYCARBONYL(PIPERAZINO)]PYRIDINE
butyl 4-(3-aminopyridin-2-yl)piperazine-1-carboxylate
3-Amino-2-[4-tert-butoxycarbonyl(piperazino)]pyridine
tert-butyl 4-(3-amino-2-pyridyl)piperazine-1-carboxylate
ert-butyl4-(3-aminopyridin-2-yl)piperazine-1-carboxylate
3-Amino-2-[4-tert-butoxycarbonyl(piperazino)]pyridine ,97%
tert-butyl 4-(3-aminopyridin-2-yl)piperazine-1-carboxylate
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
制備方法

153473-24-6
![3-氨基-2-[4-叔丁氧基羰基(哌嗪基)]吡啶](/CAS/GIF/111669-25-1.gif)
111669-25-1
以4-(3-硝基吡啶-2-基)哌嗪-1-羧酸叔丁酯(350 mg,1.14 mmol)為原料,將其與Pd/C(60.4 mg,10% w/w,0.0568 mmol)和甲醇(6 mL)混合。在室溫下,使用氫氣球提供氫氣氛圍進(jìn)行氫化反應(yīng)。反應(yīng)混合物攪拌2小時后,通過硅藻土過濾以去除催化劑。濾液經(jīng)減壓濃縮后,通過硅膠柱色譜法(洗脫劑比例為己烷/EtOAc/CH2Cl2 = 1:1:1)純化,得到目標(biāo)產(chǎn)物4-(3-氨基吡啶-2-基)哌嗪-1-羧酸叔丁酯(246 mg,產(chǎn)率78%),為白色粉末。質(zhì)譜(EI)分析結(jié)果:C14H22N4O2的分子離子峰(MH+)為279.2。
參考文獻(xiàn):
[1] Journal of Medicinal Chemistry, 1994, vol. 37, # 7, p. 999 - 1014
[2] Patent: WO2012/61337, 2012, A1. Location in patent: Page/Page column 45
[3] Patent: WO2008/112440, 2008, A1. Location in patent: Page/Page column 38-39
[4] Chemical and Pharmaceutical Bulletin, 2001, vol. 49, # 11, p. 1406 - 1411
[5] Journal of Labelled Compounds and Radiopharmaceuticals, 2011, vol. 54, # 7, p. 363 - 366